Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on the bearish thesis of PFE stock.
Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, UBS initiated coverage of ...
Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens ...
Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the former's historical data "to create state-of-the-art, exclusive models for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback